Wegovy and similar weight-loss medications are becoming widely prescribed for teenagers with obesity, but little is known ...

As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim ...

These are just some of the ways in which analysts forecast that the new wave of incredibly effective weight-loss drugs, known ...

Obesity caused by a lifestyle of moving less and eating more is a prime factor contributing to Type 2 diabetes. Is the answer new weight loss drugs?

Nov. 6, 2024 – The FDA has updated the labels for all GLP-1 weight loss drugs with a warning about pulmonary aspiration ...

The drugmaker hopes to show CagriSema leads to at least 25% weight loss, without increased side effects. Its lead in a ...

The lowest dose of Novo Nordisk's weight-loss drug, Wegovy, was listed as available on the U.S. health regulator's website on Wednesday.

Eli Lilly, the maker of the popular weight loss drug Zepbound, revealed a "shocking first miss" during its most recent ...

New, popular injectable weight loss drugs — GLP-1 drugs — are ... up from $125 million in 2022. Already in 2022, GLP-1 drugs accounted for 5 percent of pharmacy spending among people with ...

Despite the boom in popularity of expensive GLP-1 drugs to treat weight loss, fewer than one in ... [+] five large employers are covering such prescriptions, a new KFF analysis shows. In this ...

Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a shortage of the brand-name drug has ended – which means compounding of the ...